人工智能在骨髓剂量测量和个性化放射性干治疗中的未来前景
Alexandros Moraitis1, Alina Küper1, Johannes Tran-Gia2
1Department of Nuclear Medicine, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Seminars in nuclear medicine
|July 16, 2024
概括
人工智能 (AI) 可以通过提高剂量测量准确性和预测血液风险来增强放射性子疗法. 这种个性化的方法旨在优化患者选择和治疗计划,以获得更安全,更有效的癌症护理.
科学领域:
- 核医学就是核医学.
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 放射性干疗法提供了有效的癌症治疗方法,但会带来血液学副作用的风险,如贫血和血栓塞缩小症.
- 综合剂量测量对于管理新型治疗药物的安全性和有效性至关重要.
- 基于预测不良事件的风险因素进行个性化患者管理和选择仍然是一个挑战.
研究的目的:
- 审查人工智能 (AI) 方法在核医学剂量计中的整合.
- 探索AI在改善骨髓和血液剂量计准确度方面的潜力.
- 为了能够及早识别血液学风险因素,并促进适应性治疗规划.
主要方法:
- 对人工智能在剂量计中的应用现有文献的综述.
- 讨论用于预测建模的机器学习和深度学习算法.
- 在相关学科中探索成功的AI实现.
主要成果:
- 人工智能为提高骨髓和血液剂量计的准确性提供了重大机会.
- 人工智能可以促进早期检测患有血液学不良事件风险的患者.
- 人工智能可以为个性化的放射性连接体疗法提供适应性治疗计划.
结论:
- 人工智能在剂量测量中的整合即将彻底改变放射性体疗法.
- 人工智能辅助的预测剂量测量与临床数据相结合,将推动个性化治疗.
- 未来的方向包括开发强大的AI模型,用于风险分层和治疗优化.
更多相关视频
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.2K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
相关概念视频
01:22Bone Marrow Sampling and Transplants
321
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
321
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K